Milk of Magnesia Institutional Units Recalled for Manufacturing Quality Deviation
Plastikon Healthcare LLC is recalling 5,400 unit doses of Milk of Magnesia USP (Lot 20041A, exp. May 2022) due to failure to properly investigate failed microbial testing during manufacturing. The product was distributed in Indiana for further distribution nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving CGMP deviation with failure to properly investigate failed microbial testing. The recall presents a risk of potential product contamination due to inadequate investigation, but no illnesses or injuries have been reported. The hazard is theoretical pending proper investigation, placing this in the High severity category per the rubric.
Plain-English summary
Plastikon Healthcare LLC, distributed by Major Pharmaceuticals in Livonia, Michigan, is recalling 5,400 unit doses of Milk of Magnesia USP (2400 mg/30 mL) packaged in 30 mL cups. The affected product is Lot 20041A with an expiration date of May 2022.
The recall is due to a Current Good Manufacturing Practice (CGMP) deviation identified during manufacturing. Specifically, the manufacturer failed to properly investigate the results of failed microbial testing, which means the product may not have undergone adequate quality assurance procedures to ensure safety and efficacy.
This product is for institutional use only and was distributed in Indiana for further distribution throughout the United States.
Healthcare facilities and institutional pharmacies that received product from the affected lot should stop use immediately. Return the product to Major Pharmaceuticals or consult the distributor for proper disposition instructions.
The recalled product
- Product
- MILK OF MAGNESIA USP, (Magnesium Hydroxide), 2400 mg/30 mL, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Distributed by Major Pharmaceuticals, Livonia, MI 48152, NDC 0904-6846-73.
- Manufacturer
- Plastikon Healthcare LLC
- Category
- Drug — Laxative
- Affected units
- 5,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 20041A
- EXP May 2022
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by Plastikon Healthcare LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Plastikon Healthcare LLC
See all →- ModerateAntacid Suspension Recalled Due to Manufacturing Process Control Deviations
FDA (Drugs) · 2022-09-14
- HighAcetaminophen Oral Solution 160 mg Recalled for Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
- SevereAntacid Oral Suspension Recalled Nationwide for Microbial Contamination
FDA (Drugs) · 2022-09-14
- HighGuaifenesin and dextromethorphan liquid medication recalled for manufacturing control issues
FDA (Drugs) · 2022-09-14
- ModerateAcetaminophen Oral Solution Recalled Due to Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19